[IMCAS World 2026 Special] Shaping the Future: K-Medical Aesthetics Leading Innovation ⑯ | Interview with Sean Yu, Head Managing Director, Overseas Sales Dept., Bluecore Company
Backed by proprietary three-stage energy amplification technology and more than 45 patents, Bluecore Company is making its mark on the global medical aesthetics device market with its tri-wavelength diode laser 'Trinity' and next-generation picosecond laser 'PicoreMax.' At IMCAS World Congress 2026, the company showcased its multi-indication lineup covering lifting, pigmented lesion treatment, and hair removal, drawing strong interest from international buyers. Now present in 53 countries with U.S. FDA clearance secured for all seven products in its portfolio, Bluecore Company continues to expand — with two additional FDA clearances slated for the first and second halves of this year. At the Paris venue, Sean Yu, Head Managing Director of Overseas Sales at Bluecore Company, noted that "there is growing demand for 'smart all-in-one' devices that can address multiple indications in a single platform," adding that "as a young and energetic company, we are not afraid to fail and will continue to push forward aggressively."
#MedicalAestheticNews #IMCAS2026 #BluecoreCompany #Trinity #PicoreMax #KMedicalAesthetics
★ Article Link: https://www.aestheticnews.co.kr/news/articleView.html?idxno=11232

Comments
Post a Comment